The Molecular Biology of Progesterone Receptors: Why Are There Two Isoforms?

  • K. B. Horwitz
  • L. Tung
  • G. S. Takimoto
Conference paper
Part of the Ernst Schering Research Foundation Workshop book series (SCHERING FOUND, volume 18)

Abstract

Progesterone is the reproductive and pregnancy hormone. Females without it are infertile. The major target tissues for progesterone are the ovary, uterus, mammary gland, and brain. Synthetic progestational agents are used for contraception and hormone replacement therapy and antiprogestins are in clinical trials for contraception and for the treatment of cancers and uterine disorders. The agonists and antagonists act at their target tissues by binding to progesterone receptors (PR) which consist of two isoforms: human B receptors (hPRB) are 933 amino acids in length, while human A receptors (hPRA) lack the N-terminal 164 amino acids, but are otherwise identical to B receptors. When A and B isoforms are present in equimolar amounts, they dimerize and bind DNA as three species: A/A and B/B homodimers, and A/B heterodimers. This heterogeneity has complicated the study of antiprogestins since each isoform and dimeric species has a unique ligand response profile that varies with the gene and cell in question (Horwitz 1992, and references therein). This chapter reviews recent work from our laboratory dealing with the two isoforms of human PR, focusing on antiprogestin actions in breast cancer cells. These studies have allowed us to pose, but not yet answer, the question in the title of this chapter.

Keywords

Zinc Estrogen Serine Dexamethasone Glucocorticoid 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cairns C, Cairns W, Okret S (1993) Inhibition of gene expression by steroid hormone receptors via a negative glucocorticoid response element. DNA Cell Biol 12:695–702PubMedCrossRefGoogle Scholar
  2. Cato ACB, Henderson D, Ponta H (1987) The hormone response element of the mouse mammary tumor virus DNA mediates the progestin and androgen induction of transcription in the proviral long terminal repeat region. EMBO J 6:363–368PubMedGoogle Scholar
  3. Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR (1990) Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249:1266–1272PubMedCrossRefGoogle Scholar
  4. Gruol DJ, Campbell NF, Bourgeois S (1986) Cyclic AMP-dependent protein kinase promotes glucocorticoid receptor function. J Biol Chem 261:4909–4914PubMedGoogle Scholar
  5. Härd T, Kellenbach E, Boelens R et al (1990) Solution structure of the glucocorticoid receptor DNA-binding domain. Science 249:157–160PubMedCrossRefGoogle Scholar
  6. Horwitz KB (1992) The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer? Endocr Rev 13:146–163PubMedGoogle Scholar
  7. Horwitz KB, McGuire WL, Pearson OH, Segaloff A (1975) Predicting response to endocrine therapy: a hypothesis. Science 189:726–727PubMedCrossRefGoogle Scholar
  8. Jonat C, Rahmsdorf HJ, Park K-K, Cato AC, Gebel S, Ponta H, Herrlich P (1990) Antitumor promotion and antiinflammation: down-modulation of AP-1 (fos/jun) activity by glucocorticoid hormone. Cell 62:1189–1204PubMedCrossRefGoogle Scholar
  9. Kutoh E, Stromstedt P-E, Poellinger L (1992) Functional interference between the ubiquitous and constitutive octamer transcription factor 1 (OTF-1) and the glucocorticoid receptor by direct protein-protein interaction involving the horneo subdomain of OTF-1. Mol Cell Biol 12:4960–4969PubMedGoogle Scholar
  10. McDonnell DP, Goldman ME (1994) RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism. J Biol Chem 269:11945–11949PubMedGoogle Scholar
  11. Meyer ME, Gronemeyer H, Turcotte B, Bocquel M-T, Tasset D, Chambon P (1989) Steroid hormone receptors compete for factors that mediate their enhancer function. Cell 57:433–442PubMedCrossRefGoogle Scholar
  12. Miner JN, Yamamoto KR (1991) Regulatory cross-talk at composite response elements. Trends Biol Sci 16:423–426CrossRefGoogle Scholar
  13. Mohamed KM, Tung L, Takimoto GS, Horwitz KB (1994) The leucine zippers of c-Fos and c-Jun for progesterone receptors dimerization: mechanisms of A-dominance in the A/B heterodimer. J Steroid Biochem Mol Biol 51:241–250PubMedCrossRefGoogle Scholar
  14. Oro AE, Hollenberg SM, Evans RM (1988) Transcriptional inhibition by a glucocorticoid receptor-β-galactosidase fusion protein. Cell 55:1109–1114PubMedCrossRefGoogle Scholar
  15. O’Shea EK, Rutkowski R, Stafford WF III, Kim PS (1989) Preferential heterodimer formation by isolated leucine zippers from Fos and Jun. Science 245:646–648PubMedCrossRefGoogle Scholar
  16. Sakai DD, Helms S, Carlstedt-Duke J, Gustafsson JÅ, Rottman FM, Yamamoto KR (1988) Hormone-mediated repression of transcription: a negative glucocorticoid response element from the bovine prolactin gene. Genes Dev 2:1144–1154PubMedCrossRefGoogle Scholar
  17. Sartorius CA, Tung L, Takimoto GS, Horwitz KB (1993) Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP. J Biol Chem 5:9262–9266Google Scholar
  18. Sartorius CA, Groshong SD, Miller LA, Powell RL, Tung L, Takimoto GS, Horwitz KB (1994a) New T47D breast cancer cell lines for the independent study of progesterone B- and A receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP. Cancer Res 54:3868–3877PubMedGoogle Scholar
  19. Sartorius CA, Melville MY, Hovland AR, Tung L, Takimoto GS, Horwitz KB (1994b) A third transactivation function (AF3) human progesterone receptors located in the unique, N-terminal segment of the B-isoform. Mol Endocrinol 8:1347–1360PubMedCrossRefGoogle Scholar
  20. Schule R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma IM, Evans RM (1990) Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62:1217–1226PubMedCrossRefGoogle Scholar
  21. Truss M, Beato M (1993) Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr Rev 14:459–479PubMedGoogle Scholar
  22. Truss M, Bartsch J, Beato M (1994) Antiprogestins prevent progesterone receptor binding to hormone responsive elements in vivo. Proc Natl Acad Sci USA 91:11333–11337PubMedCrossRefGoogle Scholar
  23. Tung L, Mohamed KM, Hoeffler JP, Takimoto GS, Horwitz KB (1993) Antagonist occupied human progesterone B-receptors activate transcription without binding to progesterone response elements, and are dominantly inhibited by A-receptors. Mol Endocrinol 7:1256–1265PubMedCrossRefGoogle Scholar
  24. Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O’Malley BW, McDonnell DP (1993) Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol 7:1244–1255PubMedCrossRefGoogle Scholar
  25. Yang-Yen H-F, Chambard J-C, Sun Y-L, Smeal T, Schmidt TJ, Drouin J, Karin M (1990) Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205–1215PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • K. B. Horwitz
  • L. Tung
  • G. S. Takimoto

There are no affiliations available

Personalised recommendations